DOCSLIB.ORG

Fmri) and Positron Emission Tomography (PET) in Patients with Mild Alzheimer's Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fmri) and Positron Emission Tomography (PET) in Patients with Mild Alzheimer's Disease University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2002 Investigation of Cognitive Impairments using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) in patients with mild Alzheimer's disease Mateja de Leonni Stanonik University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Medicine and Health Sciences Commons Recommended Citation Stanonik, Mateja de Leonni, "Investigation of Cognitive Impairments using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) in patients with mild Alzheimer's disease. " PhD diss., University of Tennessee, 2002. https://trace.tennessee.edu/utk_graddiss/2199 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Mateja de Leonni Stanonik entitled "Investigation of Cognitive Impairments using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) in patients with mild Alzheimer's disease." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Doctor of Philosophy, with a major in Comparative and Experimental Medicine. Joseph H. Dougherty, Major Professor We have read this dissertation and recommend its acceptance: Karl F. Hubner, R. Kent Hutson, Joseph A. Thie, Joel Lubar, Gary T. Smith, Xuemin Xu Accepted for the Council: Carolyn R. Hodges Vice Provost and Dean of the Graduate School (Original signatures are on file with official studentecor r ds.) To the Graduate Council: I am submitting here with a dissertation written by Mateja de Leonni Stanonik entitled "Investigation of Cognitive Impairments using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) in patients with mild Alzheimer's disease". I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Comparative and Experimental Medicine. John H. Dougherty, Major Professor We have read this dissertation and recommend its acceptance: Karl F. Hübner R. Kent Hutson Joseph A. Thie Joel Lubar Gary T. Smith Xuemin Xu Accepted for the Council: Dr. Anne Mayhew Vice Provost and Dean of Graduate Studies (Original signatures are on file in the Graduate Student Services Office.) Investigation Of Cognitive Impairments Using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) In Patients With Mild Alzheimer’s Disease A Dissertation Presented for the Doctor of Philosophy Degree The University of Tennessee, Knoxville Mateja de Leonni Stanonik May, 2002 Copyright © Mateja de Leonni Stanonik, 2002 All rights reserved ii Dedication This dissertation is dedicated to Prof. Dr. John H. Dougherty Jr., M.D. Whose sound advice, affectionate mentorship, careful supervision, and uncompromizing support motivate my continuous fascination with the intricacies of the human mind. Eppur, si muove. Gallilleo Disertacija je posveèena mojemu professorju ter mentorju Prof. Dr. John H. Dougherty Jr., M.D. Uspeh, ki ga ta disertacija predstavlja, mi je bil omogoèen zaradi njegove neomejene podpore, ljubezni, vseh požrtvovanj ter skrbnega nadzora. iii Acknowledgements No matter how independent I like to think myself, I could not have completed this thesis without the help of many good people to whom I owe at great amount of debt and gratitude. At the top of the list is Charles A. Licata, whose patience, care, and support rarely wavered over the three years this project required. In addition to his personal support, I could have never completed the project without his help and guidance in statistics, psychometrics, and above all without his expertise in computer programming and computer technology. Obtaining my Ph.D. degree represents one of the milestones in my life and carries an even greater personal affective significance since I had to leave my homeland in pursuit of higher education in the area of my interest – affective neuroscience. Luck, persistence, and hard work have finally resulted in the completion of a truly interdisciplinary as well as multidisciplinary approach to the study of cognitive changes in early Alzheimer’s disease. Many people who have noticed my fascination with the human brain have helped me along the way, however there are a few persons who directly influenced my educational career. I would like to single out and express my tremendous gratitude to Dr. Karl F. Hübner, M.D., a professor who served as a mentor on my doctoral committee. Dr. Hübner’s excitement, knowledge, patience and generosity ignited my interest in functional neuroimaging while I was still an undergraduate. Subsequent completion iv of my senior honors thesis on a project evaluating tumor recurrence with 11C-ACBC also provided me with the basics of PET methodology. In addition, Dr. Hübner became my first true mentor, a person I trusted and whom I will always look up to. It is difficult for me to believe that there are no coincidences in life for it was Dr. Hübner who yet again changed my life several years later by introducing me to the person who became my major professor during my doctoral studies and enabled me to explore cognitive impairments in early Alzheimer’s patients. Dr. Hübner has been the calming and powerful presence during the course of my studies who helped weather even the most trying of circumstances. If the completion of this degree presents any measure of success in pursuit of multidisciplinary research, it is a prominent reflection of Dr. Hübner’s care, guidance, care, and respect for my interests in neuroimaging in addition to my fascination with the human mind. For this, I extend Dr. Karl F. Hübner my deepest appreciation and gratitude. Similarly, I also owe Dr. Hübner many thanks for suggesting excellent professors who agreed to serve on my doctoral committee. I would like to thank Dr. Gary T. Smith, M.D., for sharing with me his expertise in Nuclear Medicine in teaching me about PET. Furthermore, I have been most honored that Dr. R. Kent Hutson, M.D., agreed to join my doctoral committee. He taught me almost everything I know about neuroanatomy, MRI, functional MRI, computers, and image processing. In addition, his invaluable expertise in Neuroradiology has contributed to a broader education than most students in neuroscience normally receive. I am very much looking forward to working on other research projects in the future with Drs. Smith and Hutson. v Furthermore, I would like to thank Dr. Joseph A. Thie, Ph.D., for providing me with his tremendous knowledge of statistics. His suggestions and expedient review of my written pursuits have guided me through the tricky portions and interpretations of statistical results in this study. Finally, I would like to thank Dr. Joel Lubar, Ph.D. and Xuemin Xu, Ph.D., for sharing with me their expertise in neuropsychology, neuroanatomy, and pathology of AD. Of course, this study would not have been possible without the AD patients and control participants. I thank all of them for their contributions as well. A bird sings not because it has an answer, but because it has a song. (Herman de Zwaan, 1899) Whatever accomplishment is presented by the completion of my doctorate would have been impossible without my friends whom I have come to consider my family in the United States. I would like to thank all of those who helped me pursue my higher education when I first came to this country. Without the encouragement and financial support of Drs. Bruce and Shirley Avery, without the guidance, care, and financial support of Mr. James Domina and his family, without the support of a most excellent teacher and my dear friend, Mrs. Tommye Sue McGinnis and her husband Gary McGinnis, without the love and encouragement of Ms. Deanna Burnett, her daughter Stephanie and her son Joshua, without the encouragement of such friends as Mary Lou Horner, Sandra Clark, Dave and Katherine Long, Jerry Galyean, and Bob Griffits, I would have never achieved my goal of becoming a doctor. To all of you, I owe my deepest appreciation and gratitude. It is a humbling but equally joyous experience to consciously realize how many good vi people have touched my life in so many different ways. It has been a privilege to know you for you have all become a part of my family. Only through experiences of the last decade have I realized that I carry a great responsibility to give something back to the amerian community from which I have so generously received. After everything is done and said, the main reason for the success exhibited by the completion of my doctorate was made possible because of my mother, Mrs. Vita Stanonik. Her unconditional love, great courage, enormous strength, unrestricted support, and above all her trust and courage to “alow me to spread my wings and experience life on my own terms at such a young age” is truly a reflection of her trust and love for her me. Moja mami me je nauèila, da v življenju obstajajo razliène ljubezni, ki zmešajo glavo, èute, duha in srce; med vsemi pa je ena sama, ki ne zmede, ampak prodre v globino in ta umrje edino le z bitjem, v katerem se je zakoreninila. Zaradi njene neomejene ljubezni do vseh mojih slabosti in prednosti, mi je bil omogoèen uspeh, ki ga predstavlja moj doktorat. “Mami, ustvarila si prvega Dr. Stanonik v naši družini – bodi ponosna nase!” vii Abstract Awareness and interest in diseases, which pertain to cognitive and affective functions in the elderly, has been increasing, as the proportion of elderly people in the population grows larger.
Load more

Recommended publications
  • NEGLECT and ANOSOGNOSIA a CHALLENGE for PSYCHOANALYSIS Psychoanalytic Treatment of Neurological Patients with Hemi-Neglect
    Psychoanalytische Perspectieven, 2002, 20, 4: 611-631 NEGLECT AND ANOSOGNOSIA A CHALLENGE FOR PSYCHOANALYSIS Psychoanalytic treatment of neurological patients with hemi-neglect Klaus Röckerath1 Introduction This paper deals with two phenomena often observed in patients with a lesion to the right hemisphere of the brain: neglect and anosognosia. Fol- lowing an overview of the neglect syndrome from a neuroscientific per- spective I will present preliminary results and hypotheses formulated by our group based on the psychoanalytic treatment of seven such patients. It may be somewhat unusual for neurologically impaired patients to undergo psychoanalytic treatment. But in recent years, a combined effort to under- stand the underlying mechanisms of psychic phenomena has evolved in psychoanalysis and the neurosciences. Hence, the field of neuro-psycho- analysis established itself, studying the psychic implications of neurologi- cal damage in order to understand and gain insight into the "psychic appa- ratus", as constructed by Freud, from a different point of view. It is well known that Freud, a trained neurologist, hoped that one day the mecha- nism of psychic functions would be understood from a neurologist's point of view. He was convinced that the answer to the psychic problems he encountered with his patients must be rooted in the matter of the mind: the brain. That is why groups of psychoanalysts and neuroscientists all over the world have begun to exchange news and views about their common interest: the human mind. Both sciences basically deal with the same object. One way psychoanalysts can contribute is by looking at neurologically impaired patients in a psychoanalytic framework to establish what is dif- 1.The Neurops ychoanalytic Study Group Frankfurt/Cologne, Germany.
    [Show full text]
  • Neuroradiology of Non-Alzheimer's Disease Dementias
    Hong Kong J Radiol. 2015;18:58-73 | DOI: 10.12809/hkjr1414267 PICTORIAL ESSAY Neuroradiology of Non-Alzheimer’s Disease Dementias YL Dai1, K Wang1, TCY Cheung1, DLK Dai2 1Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong; 2Department of Medicine and Therapeutics, Prince of Wales Hospital, Hospital Authority, Hong Kong ABSTRACT Dementia is an increasingly prevalent disease of the ageing population. Although Alzheimer’s disease is still the most common cause of dementia, there is emerging clinical interest in other, less common, causes of dementia that can affect patients at a younger age. Early diagnosis of these non-Alzheimer’s disease dementias is now possible with the aid of neuroimaging, including computed tomography and magnetic resonance imaging, as well as newer modalities such as magnetic resonance spectroscopy, diffusion tensor imaging, and single-photon emission computed tomography. The imaging features of some of the more common non- Alzheimer’s disease dementias will be discussed in this review in order to help clinicians and radiologists better diagnose these conditions. Key Words: Alzheimer disease; Aphasia, primary progressive; Dementia, vascular; Magnetic resonance spectroscopy; Multiple system atrophy 中文摘要 非阿爾茨海默病癡呆症的神經放射學 戴毓玲、王琪、張智欣、戴樂群 隨着人口老化，老年癡呆症患者愈發普遍。雖然阿爾茨海默氏症仍然是老年癡呆症最常見的病因， 但臨床對於更年輕患者的其他較少見的病因頗有興趣。神經影像技術有助於非阿爾茨海默氏病的癡 呆症的早期診斷，包括電腦斷層掃描和磁共振成像，以及較新型的技術如磁共振波譜、彌散張量成 像和單光子發射電腦斷層掃描。本文討論一些較常見的非阿爾茨海默病癡呆症的影像學特徵，以幫 助臨床醫生和放射科醫生更好地診斷此類病症。 INTRODUCTION focal brain lesions and identifying surgically rectifiable The prevalence of dementia in people aged 60 years or causes, such as chronic subdural haematomas, to older in Hong Kong in 2009 was 7.2% and is expected arriving at a specific antemortem diagnosis that has a to further increase with the ageing population.1 Imaging profound impact on clinical management and prognostic for dementia has long progressed from exclusion of value.
    [Show full text]
  • Amsterdam Executive Functions
    Executive function and behaviour Masud Husain Professor of Neurology & Cognitive Neuroscience, University of Oxford Lead for Neurological Conditions, Oxford NIHR Biomedical Research Centre Supported by The Wellcome Trust What are executive functions? They’re functions that are thought to be deployed when control needs to be exerted § Typically described as ‘supervisory’ or ‘controlling’ § Deployed when a situation is novel or difficult § When you need to pay attention because there isn’t an automatic / habitual response to the problem or the automatic response would be inappropriate Example: When the phone rings in someone else’s house, you don’t pick it up, even though the automatic tendency in your own home is to do so § When several cognitive processes need to be co-ordinated § Or when you need to shift from one type of process to another Orchestration of behaviour They’re functions that are thought to be deployed when control needs to be exerted § Initiate § Maintain / Sustain / Invigorate / Energise § Stop ongoing action § Inhibit inappropriate behaviour or prepotent response § Switch to a different behavioural set / set shifting / mental flexibility § Working memory: manipulation of items in short term memory § Monitor consequences of behaviour / error monitoring § Planning and prioritization § Multi-tasking § Social / emotional engagement When executive function breaks down There might be profound consequences Executive function Associated executive dysfunction Clinical presentation Task initiation Reduced self-generated behaviours
    [Show full text]
  • Cognitive Impairment in Depression: Recent Advances and Novel Treatments
    Neuropsychiatric Disease and Treatment Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Cognitive impairment in depression: recent advances and novel treatments This article was published in the following Dove Press journal: Neuropsychiatric Disease and Treatment Giulia Perini1,2 Abstract: In the past, little or no attention was paid to cognitive disorders associated with Matteo Cotta Ramusino1,2 depression (a condition sometimes termed pseudodementia). However, recent years have Elena Sinforiani1 seen a growing interest in these changes, not only because of their high frequency in acute- Sara Bernini1 stage depression, but also because they have been found to persist, as residual symptoms (in Roberto Petrachi3 addition to affective and psychomotor ones), in many patients who respond well to anti- fi Alfredo Costa1,2 depressant treatment. These cognitive symptoms seem to impact signi cantly not only on patients’ functioning and quality of life, but also on the risk of recurrence of depression. 1 Center of Cognitive and Behavioral Therefore, over the past decade, pharmacological research in this field has focused on the Disorders, IRCCS Fondazione Mondino, National Institute of Neurology, Pavia, development of new agents able to counteract not only depressive symptoms, but also Italy; 2Department of Brain and Behavior, cognitive and functional ones. In this context, novel antidepressants with multimodal activity 3 University of Pavia, Pavia, Italy; Unit of have emerged. This review considers the different issues, in terms of disease evolution, Mood Disorders, Psychiatry Service, ASST, Acqui Terme, Alessandria, Italy raised by the presence of cognitive disorders associated with depression and considers, particularly from the neurologist’s perspective, the ways in which the clinical approach to cognitive symptoms, and their interpretation to diagnostic and therapeutic ends, have chan- ged in recent years.
    [Show full text]
  • FDG PET for the Diagnosis of Dementia
    PET for Clinicians Christopher C. Rowe MD FRACP Austin Health University of Melbourne PET in dementia is not new but only in recent years, as PET has become more accessible, has a clinical role emerged. Austin Health, Melbourne does 1000 brain PET per year. Parieto-temporal hypometabolism in AD Clinical Diagnosis of AD • Sensitivity 80%, Specificity 70% (Knopfman, Neurology 2001- average of 13 studies with pathological confirmation) i.e. diagnosis requires dementia and only has moderate accuracy Mild Cognitive Impairment (MCI) does not equate to early AD • Only 50% of MCI will progress to AD dementia • 15-20% have other dementias. • 35-40% do not develop dementia. We need biomarkers for early diagnosis of AD and other dementias! New Research Criteria for AD (2007)* • dementia or significant functional impairment is NOT required • clear history of progressive cognitive decline • objective evidence from psychometric tests of episodic memory impairment • characteristic abnormalities in the CSF or in neuroimaging studies (MRI, FDG-PET, Aβ PET) *Dubois B, Feldman HH, Jacova C, et al. Lancet 2007. FDG PET in Alzheimer’s disease Parietotemporal hypometabolism Reiman EM et al. New Engl J Med 1996;334(12):752–758. View in AC-PC plane bottom of frontal lobe and occipital lobe on same horizontal plane in mid sagittal image Prefrontal Primary sensori-motor cortex Parietal Austin & Repatriation Medical Centre Department of Nuclear Medicine & Centre for PET Reading Brain PET Compare: • parietal vs sensori-motor and frontal • posterior cingulate vs
    [Show full text]
  • Vanderbilt-Veterans Affairs Internship in Professional Psychology
    Vanderbilt‐Veterans Affairs Internship in Professional Psychology Information Brochure 2017‐2018 Recruitment Cycle Vanderbilt University School of Medicine Vanderbilt University Psychological and Counselling Center Veterans Affairs Tennessee Valley Healthcare System 1 Program At‐a‐Glance The Vanderbilt University (VU)‐Department of Veterans Affairs (VA) Internship in Professional Psychology is a cooperative effort between the VU Department of Psychiatry & Behavioral Sciences and the VA. The Internship is a consortium consisting of the VU Department of Psychiatry & Behavioral Sciences, Divisions of Adult Psychiatry and Child & Adolescent Psychiatry, and Psychological and Counseling Center (PCC); and the Alvin C. York and Nashville campuses of the VA Tennessee Valley Healthcare System (TVHS). The Consortium’s organizations are located in a large university medical center in Nashville, with the exception of the Alvin C. York campus which is located about 37 miles away in Murfreesboro. The Consortium is a member of the Internship and Postdoctoral Programs in Professional Psychology (AAPIC) and has been continuously approved by the American Psychological Association (APA) since 1971. An APA site visit was completed in 2013 and the Consortium was approved for the maximum 7 years. Key details of the internship are briefly reviewed below. For complete details on specific training experiences and application requirements/procedures, please consult the Table of Contents. TRAINING PERIOD: July 3, 2017 – June 29, 2018 (Vanderbilt Psychiatry) June
    [Show full text]
  • Epileptic Pseudodementia by Antidepressants Rojo-Moreno J1*, Valdemoro-Garcia C2, Santolaya Ochando F3 and Rojo-Valdemoro C4
    Case Report iMedPub Journals Journal Rare Disorders: Diagnosis & Therapy 2017 www.imedpub.com Vol.3 No.5:14 ISSN 2380-7245 DOI: 10.21767/2380-7245.100167 Epileptic Pseudodementia by Antidepressants Rojo-Moreno J1*, Valdemoro-Garcia C2, Santolaya Ochando F3 and Rojo-Valdemoro C4 1Department of Psychiatry, Valencia University Medical School, Spain 2Private Clinic, Valencia, Spain 3University of Valencia, Clinical Psychologist, CSM Malvarrosa, Spain 4CEU University, Valencia, Spain *Corresponding author: Rojo-Moreno J, Department of Psychiatry, Valencia University Medical School, Spain, Tel: +34-963983347; E-mail: [email protected] Received date: October 24, 2017; Accepted date: November 13, 2017; Published date: November 20, 2017 Citation: Rojo-Moreno J, Valdemoro-Garcia C, Santolaya Ochando F, Rojo-Valdemoro C (2017) Epileptic Pseudodementia by Antidepressants. J Rare Disord Diagn Ther. Vol. 3 No. 5: 14. Copyright: © 2017 Rojo-Moreno J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided, the original author and source are credited. some chronic hysterical reactions. Its use began generalized in 1961 when Kiloh considered the depression as the condition of Abstract the elderly that can be more easily confused with dementia [3]. It gains since then especially importance the concept of The authors present a case of a patient who previously depressive pseudodemencia. had depressions and that remains asymptomatic for several years, but after an uncontrolled increase of Depressive disorders, especially in the elderly have, as well tricyclic antidepressant clomipramine, an important as alterations of mood and somatic manifestations, multiple cognitive alteration appeared that remained even after cognitive disorders [4], largely determined by the lack of removing the drug with which it was related.
    [Show full text]
  • Normative Hippocampal Volumetric Measurements Using Magnetic Resonance Imaging
    Turkish Journal of Medical Sciences Turk J Med Sci (2019) 49: 1464-1470 http://journals.tubitak.gov.tr/medical/ © TÜBİTAK Research Article doi:10.3906/sag-1903-233 Normative hippocampal volumetric measurements using magnetic resonance imaging 1, 2 1 1 Meltem ÖZDEMİR *, Handan SOYSAL , Önder ERASLAN , Alper DİLLİ 1 Department of Radiology, Dışkapı Yıldırım Beyazıt Health Application and Research Center, Medical Sciences University, Ankara, Turkey 2 Department of Anatomy, Faculty of Dentistry, Yıldırım Beyazıt University, Ankara, Turkey Received: 29.03.2019 Accepted/Published Online: 22.07.2019 Final Version: 24.10.2019 Background/aim: A wide variety of neurological and psychiatric disorders have been shown to be closely related to changes in hippocampal volume (HV). It appears that hippocampal volumetry will be an indispensable part of clinical practice for a number of neuropsychiatric disorders in the near future. The aim of this study was to establish a normative data set for HV according to age and sex in the general population. Materials and methods: Hippocampal magnetic resonance imaging scans of 302 healthy volunteers were obtained using a 1.5 T unit with a 20-channel head coil. The hippocampal volumetric assessment was conducted using the volBrain fully automated segmentation algorithm on coronal oblique T1-weighted magnetization prepared rapid gradient-echo (MP-RAGE) images obtained perpendicular to the long axis of the hippocampus. The mean values of HV of groups according to age and sex were calculated. The associations between HV and age and sex were analyzed. Results: The mean HV of the study group was found to be 3.81 ± 0.46 cm3.
    [Show full text]
  • PSYCHOLOGY POSTDOCTORAL FELLOWSHIP PROGRAM (APA Accredited)
    PSYCHOLOGY POSTDOCTORAL FELLOWSHIP PROGRAM (APA Accredited) Sept. 1, 2017 – August 31, 2018 Long Island Jewish Medical Center - The Zucker Hillside Hospital Northwell Health (Formerly North Shore – LIJ Health System) Psychological Services 718-470-8390 Stewart Lipner, PhD Director of Psychological Services, LIJ and NSUH Campuses Elihu Turkel, PsyD Director of Psychology Training Fellowship Offerings Clinical Child Psychology Specialty Program (Peter J. D’Amico, Ph.D., ABPP, Director) Clinical Psychology with Geropsychology Emphasis (Mary Stephens-Levy, Ph.D., Director) PSYCHOLOGY POSTDOCTORAL FELLOWSHIP PROGRAM: 2017-18 LIJMC-ZHH OVERVIEW Postdoctoral Fellowship training is available at the Long Island Jewish Medical Center campus which includes The Zucker Hillside Hospital, the Steven and Alexandra Cohen Children's Medical Center, and Long Island Jewish Hospital. Fellowship training is available in Clinical Psychology with an Emphasis in Geropsychology and Clinical Child Psychology. These Fellowship programs are accredited by the American Psychological Association. The following section broadly describes the institutions and resources within which the Fellowship takes place. Separate descriptions of each of the Fellowship tracks and their requirements are in separate sections of this brochure. Mission of the Health System: Northwell Health strives to improve the health of the communities it serves and is committed to providing the highest quality clinical care; educating the current and future generations of health care professionals;
    [Show full text]
  • Parietal Lobes: Evolution, Neuroanatomy, and Function
    Parietal Lobes: Evolution, Neuroanatomy, and Function Charles J. Vella, PhD May 3, 2017 Intent of this lecture Parietal lobe syndromes are mostly domain of neurology, not NP But these syndromes will affect NP performance on multiple tests There are lots of anatomical references: you can always use the pdf online as reference text There are lots of unusual, sometimes rare, syndromes My objective is to have you be aware of when parietal lobe functioning is involved in something you are seeing clinically in a patient The discovery of the Parietal Lobe Franciscus Sylvius (1614-1672) Physician, physiologist, anatomist, and chemist Professor at the University of Leidon (1641) Was in the chemistry lab at the University when he discovered the deep cleft (Sylvian Fissure). History of Parietal Lobe Discovery In 1874 Bartholow recorded odd sensation from legs on stimulating post central gyrus through skull wounds Djerine – alexia , agraphia -- angular gyrus lesion Hugo Liepmann--- ideomotor & ideational apraxia in (L) sided lesion Cushing in 1909 --- Electrical stimulation in conscious human beings –– mainly tactile hallucinations; first homunculus Critchley (1953) – 1st monograph on “ The Parietal Lobes” Siegel et al. (2003) – “The Parietal Lobes” Macdonald Critchley: Parietal Lobes Parietal Lobes No independent existence as anatomical / physiological unit Operates in conjunction with brain as a whole Strategically situated between other lobes Greater variety of clinical manifestations than rest of the hemisphere Ignored in
    [Show full text]
  • The Right Hemisphere and Disorders of Cognition and Communication
    The Right Hemisphere and Disorders of Cognition and Communication Theory and Clinical Practice The Right Hemisphere and Disorders of Cognition and Communication Theory and Clinical Practice Margaret Lehman Blake, PhD 5521 Ruffin Road San Diego, CA 92123 e-mail: [email protected] Website: http://www.pluralpublishing.com Copyright © 2018 by Plural Publishing, Inc. Typeset in 10.5/14 Palatino by Flanagan’s Publishing Services, Inc. Printed in the United States of America by McNaughton & Gunn All rights, including that of translation, reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, recording, or otherwise, including photocopying, recording, taping, Web distribution, or information storage and retrieval systems without the prior written consent of the publisher. For permission to use material from this text, contact us by Telephone: (866) 758-7251 Fax: (888) 758-7255 e-mail: [email protected] Every attempt has been made to contact the copyright holders for material originally printed in another source. If any have been inadvertently overlooked, the publishers will gladly make the necessary arrangements at the first opportunity. Library of Congress Cataloging-in-Publication Data: Names: Blake, Margaret Lehman, author. Title: The right hemisphere and disorders of cognition and communication : theory and clinical practice / Margaret Lehman Blake. Description: San Diego, CA : Plural, [2018] | Includes bibliographical
    [Show full text]
  • The Pseudodementia Dilemma
    Organised by: Co-Sponsored: Malaysian Healthy Ageing Society The Pseudodementia Dilemma Dr. Prem Kumar Chandrasekaran Consultant Neuropsychiatrist Penang Adventist Hospital Content • Pseudodementia – what is it? • Types • Evolution of the term • Current thoughts • Differential diagnosis & approach Introduction • Pseudodementia a popular clinical concept • Refers to a group of disorders: 1. Depressive pseudodementia 2. Ganser’s syndrome 3. Hysterical pseudodementia 4. Simulated dementia • Sachdev et al (1990) validated the term by demonstrating longitudinally no diagnostic change (except 1) in cases of pseudodementia over a period of more than a decade Depressive pseudodementia (DPD) • Some patients with depression do not exhibit hallmarks symptoms of depression - some S/S like psychomotor retardation, anhedonia, labored thinking, slipshod behavior, failing to register events, faulty orientation and loss of recent memory should alert clinician to possibility of this category of pseudodementia • Kiloh (1961) described the above set of symptoms with additionally self-neglect and loss of weight • Post (1965) added those symptoms to observations of tremulous elderly patients with shuffling gait DPD (con’t) • Folstein and McHugh (1978) claimed both dementia and depression interact together and the term ‘pseudodementia’ a misnomer as cognitive deficits resolve when the depression resolves - suggested the term ‘dementia syndrome of depression’ • Could depression then be a reaction to cognitive impairment in dementia? - Reifler et al (1982) felt
    [Show full text]